Log In
Print this Print this

Debio 0617

  Manage Alerts
Collapse Summary General Information
Company Debiopharm Group
DescriptionMultikinase inhibitor of undisclosed oncology targets
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerAurigene Discovery Technologies Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today